SA approves Indian company to manufacture generic version of semaglutide
An Indian company has received approval from South Africa’s health regulator to make and sell a generic version of semaglutide.
This is the active ingredient in Novo Nordisk’s diabetes and weight loss drugs.
For more news, visit sabcnews.com and #SABCNews on all Social Media platforms.
